Expression of the human IGF-1 in transgenic plastids
US9605045B2 · kind B2 · utility
2Cited by
8References
9Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 25, 2014 |
| Grant date | Mar 28, 2017 |
| Priority date | — |
| Expiry date | Nov 25, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A plastid transformation vector for stably transforming a plastid genome, comprising, as operably-linked components, a first flanking sequence, a DNA sequence coding for synthetic insulin-like growth factor-1 (IGF-1s) (SEQ ID NO. 1) or a substantially homologous DNA sequence of IGF-1s, which is capable of expression in the plastid genome, and a second flanking sequence.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.